CMO Stephen Eck Departs MacroGenics; Frank Perabo Named Interim Lead

MACROGENICS INC

Stephen Eck, SVP Clinical Development and CMO, to depart MacroGenics effective Dec 31, 2025 by mutual agreement.
Frank Perabo, VP Clinical Development, will assume interim oversight of clinical development.
Company has retained executive recruiter to search for a new Chief Medical Officer.
Dr. Eck joined MacroGenics in July 2020; will receive standard severance per employment agreement upon signing release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.